ABREPTOR
Dead / Abandoned — Abandoned — no statement of use filed (as of 21 Oct 2024)
What this means for you
This application is over — abandoned 21 Oct 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97532852
- Mark type
- Stylized text
- Filed
- 03 Aug 2022
- Published for opposition
- 25 Jul 2023
- Abandoned
- 21 Oct 2024
- Attorney of record
- Kongsik Kim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparation and substance containing multispecific anyibodies for degrading receptors and extracellular proteins; pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for the prevention and treatment of cancer; medicinal preparations for the treatment of infectious diseases and for use in oncology; Virucides; Pharmaceutical and biological preparations and substances for the treatment of viral related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases and for the treatment of cancer; Pharmaceutical preparations for the treatment of viral infections
Owner
- Pinetree Therapeutics, Inc., Cambridge, MA, US
- Pinetree Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 21 Oct 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 21 Oct 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 04 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Apr 2024 — SOU EXTENSION 1 GRANTED
- 19 Mar 2024 — SOU EXTENSION 1 FILED
- 03 Apr 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Mar 2024 — SOU TEAS EXTENSION RECEIVED
- 19 Sept 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Jul 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jul 2023 — PUBLISHED FOR OPPOSITION
- 05 Jul 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Jun 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Jun 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Jun 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Jun 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED